[利用线性运输技术在制药制造业中的模式转变]
1Faculty of Life Sciences, Kumamoto University.
概括
线性运输技术为工厂运营,特别是制药制造提供了一个范式转变. 在日本推广这些先进的系统可以将其确立为全球生产技术领导者.
科学领域:
- 制造业 工程 制造工程
- 生产技术 生产技术
- 工业自动化 工业自动化
背景情况:
- 线性运输技术在欧盟工厂运营中越来越受欢迎.
- 预计这项技术将彻底改变生产方法.
- 日本有战略机会采用这些进步.
研究的目的:
- 审查生产的最先进的线性运输系统.
- 讨论这些技术在制造工厂中的应用.
- 探索日本成为全球生产技术领导者的潜力.
主要方法:
- 审查线性系统制造商提供的技术信息.
- 分析线性运输技术的建议和安装.
- 检查使用这些系统的制造公司的案例研究.
主要成果:
- 确定领先的线性运输系统及其能力.
- 评估在生产工厂中实施这些系统的可行性和好处.
- 了解目前从事线性运输技术的公司的现状.
结论:
- 线性运输技术为生产进步提供了重大机会.
- 采用战略可以加强日本在全球制造业中的地位.
- 建议对制药和其他行业进一步整合这些系统.
相关概念视频
Nonlinear Pharmacokinetics: Role of Transporters
343
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
343
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
6.6K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
6.6K
Carrier-Mediated Transport
1.4K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.4K
Cellular Membranes and Drug Transport
1.8K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.8K
Facilitated Diffusion
1.5K
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
1.5K
Modified-Release Drug Delivery Systems: Overview
69
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
69


